Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis
Clinical trial NCT02267135 · COMPLETED
Trial details
- NCT number
- NCT02267135
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-29
- Primary completion
- 2015-12-07
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.